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PURPOSE 
Small nucleolar RNAs (snoRNAs) are non-coding guide molecules that classically play an important 
role in guiding the chemical modifications of other RNAs to accommodate for changing cellular 
requirements.  SNORD32A, -33 and -35A (oxi-snoRNAs) are a unique class of snoRNAs which 
themselves are regulated by reactive oxygen species (ROS) and oxidative stress.  This is though 
guiding Nm modification of mRNA (evidenced for peroxidasin), in addition to their roles modifying 
rRNA. Furthermore others have demonstrated that they act in concert in stress response pathways. 
They are intronically encoded in the ribosomal protein host gene RLP13A. Oxidative stress, as a 
result of overwhelming ROS accumulation, significantly contributes to the ageing process.  There is 
an age-related increase in ROS resulting in oxidative stress, a predominantly catabolic process 
evident in osteoarthritis (OA), one of the most common age-related chronic diseases affecting a 
multitude of species.  
Gaining an awareness of, and elucidating the mechanisms by which abnormal tissue homeostasis 
contributes to cartilage ageing and OA-related regulatory dysfunctions, is crucial to our 
understanding of the disease. We hypothesise a role for these oxidative stress snoRNAs in cartilage 
ageing and OA.  
METHODS  
RNA was extracted from cartilage collected at total knee arthroplasty surgery from the medial (old 
normal; n=10; damaged) and lateral (old OA; n=10; intact), femoral condyles from donors aged 62.6 
± 7.3 (mean ±standard deviation) years and the lateral femoral condyle following anterior cruciate 
ligament surgery from young donors (young normal); 23.7 ± 3.8 years. Microarray analysis was 
undertaken using Affymetrix miRNA 4.0 arrays and differentially expressed (DE) snoRNAs were 
defined as FDR<0.05. Oxi-snoRNA expression was validated using qRT-PCR in independent human 
samples and equine young (2.33±1.2), old (17.67±2.5) and OA (18.67±1.2) chondrocytes.  RLP13A 
expression was measured in the independent cohort samples. Changes in expression of snoRNAs 
were studied in OA-like conditions in human articular chondrocytes (HAC) and equine chondrocytes 
using interleukin-1 (IL1β) and HAC using OA synovial fluid. HAC and equine chondrocytes were 
treated with hydrogen peroxide (50uM), or tert-butyl hydroperoxide (TBHP) (25uM) to induce 
oxidative stress and fibronectin fragments (FN -f)(1uM), to generate physiological levels of ROS.  
QRT-PCR was used to determine induction of oxidative stress (CAT, GPx5 and SOD1) and oxi-
snoRNAs expression. Phenotypic changes following SNORD-32A and-33 knockdown in SW1353 cells 
was undertaken following antisense oligonucleotides (ASO) using qRT-PCR. Phenotypic changes were 
assessed by measuring gene expression of rRNA, chondrogenic and hypertrophic genes.  
RESULTS  
Microarray analysis identified an increase in OA cartilage of SNORD33 and -35A (4.6 and 3.1. log2 
fold change). The expression of SNORD32A, -33, -35A were significantly reduced in ageing human 
cartilage (3.9, 7.2, 4.5 log2 fold change).  Using an independent cohort, the expression of SNORD32A 
(p<0.05), SNORD33 (P<0.001), SNORD35 (p<0.07) was higher in OA human cartilage (damaged) 
compared to old (intact) human cartilage. RPL13A was expressed higher in old versus OA (p<0.03) 
and young versus OA (p<0.001). In equine chondrocytes expression of SNORD32A (p<0.01), 
SNORD33 (P<0.05), SNORD35 (p<0.05) was higher in OA. In ageing HAC, we confirmed a reduction in 
SNORD33 (p<0.02) and SNORD35 (p<0.05) and in equine chondrocytes in snord32A (p<0.05) and 
snord35 (p<0.01) between young and old. 
We discovered that oxistress snoRNA expression in HAC and equine chondrocytes responds to 
catabolic and environmental conditions.  The addition of IL1β or OA synovial fluid for 24h to HAC 
increased the expression of SNORD33 (p<0.05, P<0.001). In healthy HAC there was a significant 
increase in expression of SNORD32A (p<0.001) and SNORD33 (p<0.001) following hydrogen peroxide 
treatment for 24h.  
In young equine chondrocytes whilst there was an increase in snord32A and snord33 following 
hydrogen peroxide treatment for 1h, this was only significant for snord33 (p<0.01). Following TBHP 
treatment for 48h there was an increase in snord32A in young (p<0.05) and old (p<0.05) equine 
chondrocytes, an increase in snord33 in old (p<0.05) and a non-significant increase in snord35.  
Following successful SNORD33 knockdown (p<0.008), and D32A (p<0.02) there was a reduction in 
5.8S rRNA (p<0.008), 18S rRNA (p<0.03) and 28S rRNA p<0.02), along with a reduction in SOX9 
(p<0.03) and MMP13 (p<0.01) and an increase in COL2A1 (p<0.01) (all SNORD33).  
 
CONCLUSIONS 
We identified changes in oxi-snoRNAs in ageing and OA, and this was a cross species phenomenon. 
This is interesting as not all snoRNA effects are the same between species.  We have previously 
identified RLP13A as being an age-related gene using the Human Ageing Genomics Resource. 
However in agreement with other studies oxi-snoRNA expression did not mirror host gene 
expression.  Our in vitro experiments demonstrated that oxi-snoRNAs respond to their environment 
(synovial fluid) and oxidative stress stimuli (hydrogen peroxide and TBHP). Physiological levels of ROS 
generated using FN –f increased the expression of oxi-snoRNAs but this did not reach statistical 
significance. The effects of a loss of D32A and D33 snoRNAs on cartilage homeostasis and OA 
phenotypic gene expression raises the possibility that a variation in the expression of these snoRNAs 
may contribute to the OA disease phenotype. SnoRNAs can be targeted by antisense knockdown, 
thus our findings suggest that molecular therapies could be designed to target these noncoding 
RNAs as possible future treatments in human and equine OA. We are investigating our findings 
further using induction of oxidative stress in parallel with ASO knockdown.  
